Skip to main content
. 2020 Mar 15;12(3):358–364. doi: 10.4251/wjgo.v12.i3.358

Figure 1.

Figure 1

Case 1. A: Positron emission tomography scan: the white arrow shows the area of multiple foci of fludeoxyglucose uptake in the treated area; B: Multi-phase magnetic resonance imaging scan: it shows no arterial enhancement in the same area during the arterial phase; C: Positron emission tomography scan: the arrow indicates an area of fludeoxyglucose uptake, indicating another residual tumor.